Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Eoganachton Sep 03, 2023 10:31am
239 Views
Post# 35617977

RE:RE:RE:My calculations add up to more than current sp !

RE:RE:RE:My calculations add up to more than current sp !Roswell Park uses PDCs off label for various forms of cancer.

https://www.google.com/url?sa=t&source=web&rct=j&opi=89978449&url=https://www.roswellpark.org/cancer-care/treatments/photodynamic-therapy/diseases-we-treat-pdt%23:~:text%3DRoswell%2520Park%2520physicians%2520sometimes%2520offer,be%2520effective%2520for%2520that%2520use.&ved=2ahUKEwio8bbM046BAxWqNzQIHSIdACQQFnoECA4QBQ&usg=AOvVaw3zSqymer3He65YxRnHQ4GU

Off-label use

Off-label use of a drug means that the drug has been approved by the FDA for a specific disease or condition, but it is being prescribed for a different, unapproved use or condition. FDA regulations allow doctors to prescribe medications off-label, and sometimes the medications’ effectiveness for an off-label use can lead to FDA approval for that new use. For example, sildenafil (Viagra) was originally approved by the FDA to treat angina (chest pain caused by inadequate blood flow to the heart), but off-label use showed that it could also be effective in treating erectile dysfunction.

Roswell Park physicians sometimes offer patients off-label use of Photofrin, one type of photosensitizer used in PDT, for treatment of such diseases as oral cancer. While Photofrin is not FDA-approved for oral cancer, is has been shown to be effective for that use.

Roswell Park treats these diseases with PDT off-label:

Gynecologic malignancies

Gynecologic tumors often occur in areas that can be accessed easily by the red light used in PDT. PDT with Photofrin® may be effective in certain cases for treating tumors of the vagina, vulva and cervix. In recurrent tumors, this therapy has sometimes resulted in long-lasting results.

Head & neck cancer and dysplasia

PDT can be used effectively for cancers or dysplasias (areas with abnormal cells) in the mouth, including the tongue, cheek, floor of the mouth, roof of the mouth and other areas. The majority of procedures are done on an outpatient basis.

Skin cancers

Skin cancers are treated using PDT in conjunction with the Dermatology Department at Roswell Park. These types of skin cancer may be treated effectively with PDT:

  • Basal cell carcinoma, the most common type of skin cancer
  • Bowen's disease
  • Nevoid basal cell carcinoma syndrome (NBCCS)

A menu of photosensitizers

We select from a menu of different types of photosensitizers available from pharmaceutical companies around the world, based on your specific needs, including age and overall health.




Oden6570 wrote:
99942Apophis wrote:
Oden6570 wrote: Intellectual Property 46 issued patents for PDC and laser technology in the United States, Canada and internationally1 Composition of matter patent expires in US in 2033 (Potentially 2038 with extension) 23 patents pending

Theralase-Corporate-Presentation-05-18-2023.pdf

Good read Oden6570,  my concern with overall numbers quoted in this report didn't differentiate out of their North American (91,000) or World (573,000) numbers that 75% are NMIBC and 25% are MIBC. Am I to assume that perhaps MIBC will also be treatable by Theralase? 
Someone mentioned that once approved Urologists could use Ruvidar for non label use ! I assume this means it is up to the Doc when to use. I am not sure however if I am accurate in this assumption. Perhaps others may shed light on this issue.



<< Previous
Bullboard Posts
Next >>